Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.20B P/E 12.72 EPS this Y -20.10% Ern Qtrly Grth -3.30%
Income 69.7M Forward P/E 9.37 EPS next Y -5.00% 50D Avg Chg -11.00%
Sales 1.12B PEG - EPS past 5Y - 200D Avg Chg -25.00%
Dividend 2.00% Price/Book N/A EPS next 5Y - 52W High Chg -43.00%
Recommedations 3.00 Quick Ratio 1.40 Shares Outstanding 57.70M 52W Low Chg 8.00%
Insider Own 0.47% ROA 9.64% Shares Float 53.45M Beta 0.96
Inst Own 100.01% ROE - Shares Shorted/Prior 1.96M/2M Price 20.98
Gross Margin 66.42% Profit Margin 6.23% Avg. Volume 525,672 Target Price 16.07
Oper. Margin 29.98% Earnings Date Nov 19 Volume 565,107 Change -0.90%
About Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Embecta Corp. News
11/18/24 Inside a $400 billion bet on the brain-computer interface revolution
11/12/24 UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
11/12/24 embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
11/07/24 embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell
09/04/24 Embecta Stock Gains on FDA Clearance for Type 2 Diabetes Insulin Pump
09/03/24 Embecta gets FDA nod for insulin patch pump
09/03/24 embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
08/22/24 embecta to Participate in Investor Events
08/16/24 Embecta (NASDAQ:EMBC) Is Posting Promising Earnings But The Good News Doesn’t Stop There
08/15/24 Embecta (NASDAQ:EMBC) Is Due To Pay A Dividend Of $0.15
08/12/24 Embecta Corp. (EMBC) Recently Broke Out Above the 20-Day Moving Average
08/12/24 Embecta Corp. (EMBC) Just Overtook the 200-Day Moving Average
08/11/24 Embecta Third Quarter 2024 Earnings: Beats Expectations
08/09/24 Embecta Corp. (EMBC) Tops Q3 Earnings and Revenue Estimates
08/09/24 Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results
08/09/24 embecta Announces Quarterly Cash Dividend
08/02/24 Earnings Preview: Embecta Corp. (EMBC) Q3 Earnings Expected to Decline
08/02/24 Is There An Opportunity With Embecta Corp.'s (NASDAQ:EMBC) 35% Undervaluation?
07/31/24 Is the Options Market Predicting a Spike in Embecta Corp. (EMBC) Stock?
07/29/24 Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company
EMBC Chatroom

User Image swingingtech Posted - 2 days ago

$HQY $EMBC https://wallstreetwaves.com/healthequity-hqy-shows-promise-with-3-5-gain-is-more-growth-ahead/

User Image WeeklyTrader Posted - 1 month ago

What’s your plan if $EMBC continues to drop? RSI: 38.45% 50-day MA: $14.65 200-day MA: $14.06

User Image javiarza Posted - 1 month ago

$EMBC adding more shares at 12,50€ I hope this stock will be higher in short term

User Image hgarrett Posted - 1 month ago

$EMBC Started

User Image yosiyosi Posted - 1 month ago

$EMBC buy 13.5

User Image vjtweet Posted - 2 months ago

$EMBC on buy list for tomorrow, if follows up.

User Image briefingcom Posted - 2 months ago

$EMBC: Embecta Corp. announces FDA clearance of its disposable patch pump for insulin delivery informed by the unique needs of people with type 2 diabetes https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240903063158EMBC&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image DonCorleone77 Posted - 2 months ago

$EMBC Embecta's disposable pump for insulin delivery cleared by FDA Embecta has received 510(k) clearance from the FDA for its proprietary disposable insulin delivery system. Indicated for adults who require insulin to manage diabetes, including both type 1 and type 2, the system includes a tubeless patch pump design with a 300-unit insulin reservoir that was informed by feedback from people with T2D and their healthcare providers. Embecta's patch pump development program also includes plans for a closed-loop version including an insulin-dosing algorithm in a future FDA submission.

User Image Charlestrader777 Posted - 2 months ago

$EMBC 👀

User Image Stock_Titan Posted - 2 months ago

$EMBC embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes https://www.stocktitan.net/news/EMBC/embecta-announces-fda-clearance-of-its-disposable-patch-pump-for-auga1y7lfde0.html

User Image NJgolfer Posted - 08/29/24

$EMBC strong recent performance, earnings have accelerated and exceeded estimates for 4 straight quarters. This got my attention. However, price is trapped below the AVWAP from the May 21 high of $29. From that high $EMBC proceeded to lose 68%. If $EMBC can push through $16.60 there is a volume pocket up to $19 so it could see a quick rally.

User Image MakingDreamsReality Posted - 3 months ago

PM mOOvers 👀 $CYBR -CyberArk Software Q2 2024 Adj. EPS $0.54 Beats $0.40 Estimate, Sales $224.706M Beat $219.106M Estimate $MKSI -MKS Instruments Q2 2024 Adj. EPS $1.53 Beats $1.07 Estimate, Sales $887.000M Beat $866.381M Estimate $EMBC -Embecta Q3 2024 Adj. EPS $0.74 May Not Be Comparable To $0.46 Estimate, Sales $272.500M Beat $267.435M Estimate $DAL -Delta Air Lines Pursues $500M Legal Claims Against CrowdStrike And Microsoft After July Outage Caused 7,000 Flight Cancellations; Incident's $380M Revenue Impact, $170M Non-Fuel Expenses, And $50M Lower Fuel Costs Expected To Affect Q3 2024 Results $RNA - Avidity Biosciences Announces Positive AOC 1044 Data Demonstrated Significant Increase of 25% in Dystrophin Production and Reduction of Creatine Kinase Levels to Near Normal in People Living with Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping in the Phase 1/2 EXPLORE44™ Trial

User Image DonCorleone77 Posted - 3 months ago

$EMBC Embecta reports Q3 adjusted EPS 74c, consensus 46c Reports Q3 revenue $272.5M, consensus $267.43M. "During Q3 our business performed in alignment with our expectations. We generated strong gross, operating and EBITDA margins even as revenue was impacted by the expected timing of customer orders that had positively impacted our second quarter results," said Devdatt Kurdikar, CEO. "From a year-to-date perspective, our financial results demonstrated the continued resilience and stability of our business. Additionally, I'm proud of the significant strides we have made as an organization in advancing our strategic priorities, including the transition to our own enterprise resource planning ("ERP") system, shared service capability and distribution infrastructure, which is now complete in most regions of the world. Furthermore, we made progress on our 510(k) application for the open-loop patch pump program. Lastly, given the strong year-to-date performance, coupled with our outlook for the remainder of the year, we are once again tightening and raising our fiscal 2024 outlook for certain financial metrics."

User Image Stock_Titan Posted - 3 months ago

$EMBC Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results https://www.stocktitan.net/news/EMBC/embecta-corp-reports-third-quarter-fiscal-2024-financial-n67n49qg7096.html

User Image StockInvest_us Posted - 3 months ago

Signal alert: $EMBC - PivotPoint bottom https://stockinvest.us/l/3VIJYqdXKe

User Image NVDAMillionaire Posted - 07/30/24

$EMBC Embecta Corp. (NASDAQ:EMBC): A Leading Diabetes Care Company Poised for Continued Growth http://beyondspx.com/2024/07/30/embecta-corp-nasdaqembc-a-leading-diabetes-care-company-poised-for-continued-growth/

User Image briefingcom Posted - 07/29/24

$G: Genpact has been working with Embecta ($EMBC) to support its spin-off from Becton Dickinson and Company and subsequent evolution as an independent leader in the diabetes technology market

User Image Stock_Titan Posted - 07/29/24

$EMBC $G Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company https://www.stocktitan.net/news/EMBC/genpact-supports-embecta-s-spin-off-into-an-independent-diabetes-ul6hu80ae69p.html

User Image kiwitc2000 Posted - 07/25/24

$EMBC Pullback on low volume. Just taking a breather or was that all there was?

User Image Antny Posted - 07/23/24

$EMBC embc up for sale. I'll take 25/ share and be gone.

User Image Stocksrunner Posted - 07/23/24

Tuesday Market Wrap-Up: High Turnover Breakouts Today's session saw significant activity for $SAP, $OMI, $EVRI, $GLNG, and $EMBC, all breaking out on higher-than-average turnover. Something noteworthy may be brewing.

User Image phatsuit Posted - 07/23/24

$EMBC yeah!!!

User Image phatsuit Posted - 07/23/24

$EMBC keep it up

User Image Stock_Titan Posted - 4 months ago

$EMBC embecta to Report Fiscal Third Quarter 2024 Financial Results https://www.stocktitan.net/news/EMBC/embecta-to-report-fiscal-third-quarter-2024-financial-bf0808f6zau5.html

User Image bhagyam Posted - 4 months ago

$EMBC What's going on with this bitch? I thought I almost lost all my investment in Aug calls .. and she is coming to life at the right time..

User Image ssdsddssd2 Posted - 4 months ago

$EMBC There is no reason not to see this stock pass 50 dollars in the coming years. The net income of this company only increases every quarter. There was no reason for the decline in recent months.

User Image ssdsddssd2 Posted - 4 months ago

$EMBC I really, really can't understand why their share price is going down? Their condition is good. They have more revenue, the last report was good - why does it keep going down? I only have a few hundred shares here but it's annoying and weird

User Image IsabellaDC Posted - 06/24/24

Something to buy scan spat this out. Studying - $ROIC $EMBC $XHR $AROC $ATEN and so on..

User Image Stock_Titan Posted - 06/24/24

$EMBC embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir https://www.stocktitan.net/news/EMBC/embecta-sponsored-abstracts-presented-at-american-diabetes-1ap74s67mccl.html

User Image StreetArtist Posted - 5 months ago

$STSS Top stocks that will benefit from China tariffs: $STSS $EMBC $FSLR

Analyst Ratings
Morgan Stanley Underweight Jul 15, 24
Morgan Stanley Underweight May 10, 24
Morgan Stanley Underweight Nov 22, 23
Morgan Stanley Underweight Oct 18, 23
Morgan Stanley Underweight Aug 24, 23
Morgan Stanley Underweight Jul 18, 23
Morgan Stanley Underweight May 15, 23
Morgan Stanley Underweight Jan 6, 23
Morgan Stanley Equal-Weight Dec 21, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Melcher David F Director Director Sep 08 Buy 15.7662 6,233 98,271 27,698 09/08/23
Kurdikar Devdatt President and CEO President and CEO Aug 10 Buy 21.81 5,000 109,050 244,791 08/10/23
Mann Jeffrey Z SVP, GC, Head Corp... SVP, GC, Head Corp. Dev., Secy Aug 10 Buy 21.67 4,700 101,849 55,333 08/10/23
Elguicze Jacob SVP and CFO SVP and CFO Aug 10 Buy 21.6637 4,625 100,195 66,027 08/10/23
Melcher David F Director Director Feb 15 Buy 32.51 3,100 100,781 21,465 02/15/23